BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SRI
Stoneridge, Inc.
There isn't enough reported data to score SRI yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
SRI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
SRI's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
SRI PE Valuation
SRI has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
SRI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect SRI's earnings to decline, with its revenue and profitability holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over SRI on earnings quality, reporting a profit while its opponent remains loss making.
SRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$4.76 | -$3.60 |
| Q2 2026 | -$4.29 | -$3.21 |
| Q1 2026 | -$4.44 | -$3.80 |
| Q4 2025 | -$3.70 | -$3.10 |
| Q3 2025 | -$1.16 | -$0.89 |
| Q2 2025 | -$1.08 | -1643% |
| Q1 2025 | -$0.64 | -$0.50 |
| Q4 2024 | -$0.60 | -$0.41 |
SRI lost $4.76 per share over the past year, a bigger loss than the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over SRI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over SRI on profitability, with a higher operating margin.
SRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $155.8M | -26% |
| Q2 2026 | $181.4M | -20% |
| Q1 2026 | $160.8M | -26% |
| Q4 2025 | $205.2M | -6% |
| Q3 2025 | $210.3M | -1.7% |
| Q2 2025 | $228M | -3.8% |
| Q1 2025 | $217.9M | -8.9% |
| Q4 2024 | $218.2M | -4.9% |
SRI's revenue has slid since its 2023 peak: $156M last quarter, down 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -14 points |
| Q2 2026 | -0.7% | +0.5 points |
| Q1 2026 | -5.6% | -4.1 points |
| Q4 2025 | -14% | -12 points |
| Q3 2025 | -1.6% | -1.7 points |
| Q2 2025 | -1.1% | -2.6 points |
| Q1 2025 | -1.5% | -1.6 points |
| Q4 2024 | -2% | -4.7 points |
SRI's operating margin was −15% last quarter, down 14 points from the same quarter a year ago, near the bottom of its range since 2019.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
SRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$236K | +$2.5M |
| Q2 2026 | $7.7M | +4.5% |
| Q1 2026 | -$12.3M | -356% |
| Q4 2025 | $2.6M | -81% |
| Q3 2025 | -$2.7M | -158% |
| Q2 2025 | $7.4M | +385% |
| Q1 2025 | $4.8M | +46% |
| Q4 2024 | $14M | +1897% |
SRI has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over SRI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
SRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +143K shares |
| 1 year | +1.9% | +528K shares |
| 3 years | +2.4% | +653K shares |
| 5 years | +4.6% | +1.2M shares |
| Available history | +0.4% | +117K shares |
SRI has 28M diluted shares, up 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $5M |
| Q4 2019 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
SRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.8x | Net Cash |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | -2.1x | Net Cash |
| Q3 2024 | -1.2x | Net Cash |
| Q2 2024 | -0.8x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -0.8x | Net Cash |
SRI has more cash than debt.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
SRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.1 | Neutral |
| Stochastic | 9.0 | Oversold |
SRI's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
SRI PE vs Consumer Cyclical Sector
| Metric | SRI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
SRI has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
SRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.92 | 14% below |
| 20 week MA | $6.68 | 24% below |
| 50 week MA | $6.70 | 24% below |
| 100 week MA | $6.37 | 20% below |
| 200 week MA | $11.5 | 56% below |
SRI is in a downtrend: it's below all five of its weekly moving averages, and 56% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
SRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.7 | $29.6 | -0.1% |
| 2021 | $29.6 | $18.7 | -37% |
| 2022 | $18.7 | $21.3 | +14% |
| 2023 | $21.3 | $19.6 | -8% |
| 2024 | $19.6 | $6.21 | -68% |
| 2025 | $6.21 | $5.69 | -8.4% |
| 2026 YTD | $5.69 | $5.09 | -11% |
SRI has the edge over BABA on returns for 2026, with the stronger performance.